April 21, 2026- McKesson Corporation announced it has entered into a definitive agreement with funds managed by affiliates of Apollo (“Apollo Funds”), under which Apollo Funds will acquire a minority ownership interest in McKesson’s Medical-Surgical Solutions (“MMS”) business. This transaction represents a meaningful milestone as McKesson executes its separation strategy of MMS … [Read more...]

April 20, 2026- Vizient® is showcasing an integrated set of supply chain capabilities at the Spring IDN Summit and Reverse Expo designed to help health systems strengthen trust across purchasing, analytics and strategic partnership. The event begins today in Orlando, Fla. The capabilities include Procure-to-Pay (P2P), the only ISO 9001 certified healthcare solution that … [Read more...]

April 20, 2026- SEKISUI Diagnostics is pleased to announce it has been awarded the Silver medal for the fourth year for its 2025 sustainability performance from EcoVadis. EcoVadis is the world’s largest provider of business sustainability ratings, placing SEKISUIDiagnostics in the 93rd percentile. The EcoVadis sustainability assessment evaluates how well a company has … [Read more...]

April 20, 2026- Medtronic plc announced it has completed its acquisition of CathWorks, a privately held medical device company, which aims to transform how coronary artery disease (CAD) is diagnosed and treated. The acquisition follows a 2022 strategic partnership with a co-promotion agreement for the CathWorks FFRangio® System where it is commercially available in … [Read more...]

April 20, 2026- Abbott will present new data at the American Association for Cancer Research (AACR) Annual Meeting 2026 demonstrating continued advancements in its multi-biomarker, multi-cancer early detection (MCED) program supporting the commercially available Cancerguard® test. Additionally, the AACR Cancer Prevention Research Award for Outstanding Journal Article will … [Read more...]

April 20, 2026- QuidelOrtho Corporation announced it has completed the acquisition of LEX Diagnostics ("LEX") for cash consideration of approximately $100 million. The LEX VELO System received U.S. Food and Drug Administration ("FDA") 510(k) clearance and CLIA waiver in February 2026. The LEX VELO System is a breakthrough molecular diagnostics platform that is designed to … [Read more...]

April 17, 2026- Intermountain Health Holy Rosary Hospital is expanding access to specialized care and surgical options for patients in Miles City, Montana, and communities across eastern Montana.  Through a partnership with Ortho Montana, Intermountain Holy Rosary Hospital will offer expanded access to orthopedic evaluation, … [Read more...]

April 17, 2026- Abbott announced financial results for the first quarter ended March 31, 2026. Continue Reading … [Read more...]

April 17, 2026- Thejus (TJ) Jayakrishnan, MD, a gastrointestinal oncologist at Dana-Farber Cancer Institute, wasn’t surprised by a recent American Cancer Society study showing that while overall cancer mortality among Americans under 50 has declined, colorectal cancer rates have risen. In fact, colorectal cancer incidence has steadily increased since 2005 and, by 2023, became … [Read more...]

April 17, 2026- Thermo Fisher Scientific Inc. announced the Applied Biosystems™ PowerFlex™ Thermal Cycler, a next-generation polymerase chain reaction (PCR) instrument designed to help deliver enhanced flexibility, precise thermal performance and improved productivity for modern molecular biology laboratories. Building on the trusted legacy of Applied Biosystems™ instruments, … [Read more...]